Press Releases Filament Health Corp.

Equities

FLHLF

CA31685W1068

Market Closed - OTC Markets Other stock markets 09:30:09 2024-05-31 am EDT			5-day change	1st Jan Change
0.0396 ^USD	-1.00%		+32.00%	-26.80%

May. 14	Filament Health Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 04	Filament Health Corp. Announces Change to Board of Directors	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS	May. 14	AQ
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS	May. 03	AQ
FILAMENT HEALTH TO DISCUSS ITS DRUG DEVELOPMENT PLATFORM IN FIRESIDE CHAT WITH WATER TOWER RESEARCH ON APRIL 4, 2024 AT 12PM ET	Apr. 03	AQ
FILAMENT HEALTH REPORTS Q4 AND YEAR END 2023 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS	Apr. 02	AQ
FILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS	Mar. 28	AQ
FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION	Mar. 19	AQ
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL	Feb. 15	AQ
FILAMENT HEALTH ANNOUNCES FDA OPENING OF INVESTIGATIONAL NEW DRUG APPLICATION FOR SUBSTANCE USE DISORDERS	Jan. 31	AQ
Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions	Jan. 31	AQ
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO AUSTRALIA	Jan. 17	AQ
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS	Jan. 02	AQ
FILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION	Dec. 20	AQ
FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE	Dec. 18	AQ
FILAMENT HEALTH ANNOUNCES ADJOURNMENT OF SPECIAL MEETING	Dec. 11	AQ
FILAMENT HEALTH FILES AMENDED PRO FORMA FINANCIAL STATEMENTS	Dec. 07	AQ
Canadian Investment Regulatory Organization Trade Resumption - FH	Dec. 06	AQ
FILAMENT HEALTH ANNOUNCES SIGNING OF DEFINITIVE AGREEMENT FOR CONVERTIBLE NOTE FINANCING, CLOSING OF C$900,000 NON-BROKERED PRIVATE PLACEMENT FINANCING, FOUNDER-LED NOTE OFFERING AND OTHER UPDATES RELATED TO UPCOMING SPECIAL MEETING AND PROPOSED BUSINESS COMBINATION	Dec. 06	AQ
Canadian Investment Regulatory Organization Trading Halt - FH	Dec. 06	AQ
FILAMENT HEALTH SIGNS NON-BINDING TERM SHEET FOR CONVERTIBLE NOTE IN CONNECTION WITH PLANNED BUSINESS COMBINATION	Nov. 23	AQ
PharmAla Biotech and Filament Health Announce Release of Second Batch of GMP MDMA Capsules	Nov. 15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Filament Health Corp.

Equities

FLHLF

CA31685W1068

Press Releases

Filters